Software Healthcare Sector

Phreesia

Market Cap: US$780.1m

Provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.

Varex Imaging

Market Cap: US$779.7m

Designs, manufactures, and sells X-ray imaging components.

Bright Minds Biosciences

Market Cap: CA$1.1b

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

AdaptHealth

Market Cap: US$775.1m

Distributes home medical equipment (HME), medical supplies, and home and related services in the United States.

SS Innovations International

Market Cap: US$766.5m

Operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally.

Cryoport

Market Cap: US$766.3m

Provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.

Phathom Pharmaceuticals

Market Cap: US$760.9m

A biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases in the United States.

Achieve Life Sciences

Market Cap: US$746.0m

A late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.

Monopar Therapeutics

Market Cap: US$741.1m

A clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.

Nanosonics

Market Cap: AU$1.0b

Operates as an infection prevention company in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific.

BridgeBio Oncology Therapeutics

Market Cap: US$739.4m

A clinical-stage biotechnology company, engages in the development of small-molecule therapeutics for the treatment of renin-angiotensin system and phosphoinositide 3-kinase malignancies in the United States.

Faeth Therapeutics

Market Cap: US$737.7m

A clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients.

Shattuck Labs

Market Cap: US$734.7m

A clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States.

CytomX Therapeutics

Market Cap: US$730.0m

Operates as an oncology-focused biopharmaceutical company that focuses on developing potent biologics designed to treat tumor microenvironment.

Claritev

Market Cap: US$715.5m

Provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.

Neurogene

Market Cap: US$713.0m

A clinical stage biotechnology company, develops genetic medicines for rare neurological diseases.

Ironwood Pharmaceuticals

Market Cap: US$712.2m

A biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally.

Crescent Biopharma

Market Cap: US$711.8m

A biotechnology company, researches and develops cancer therapy candidates in the United States.

Cybin

Market Cap: US$709.7m

Cybin Inc., doing business as Helus Pharma, a clinical stage pharmaceutical company, focuses on developing therapies to treat various psychiatric and neurological conditions.It develops HLP003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and HLP004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders.

REGENXBIO

Market Cap: US$703.7m

A clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States.

Clarity Pharmaceuticals

Market Cap: AU$981.2m

A clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States.

Gyre Therapeutics

Market Cap: US$693.5m

A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.

AgomAb Therapeutics

Market Cap: US$686.8m

A clinical-stage biopharmaceutical company, develops novel disease-modifying therapies for immunology and inflammatory diseases in the United States.

Allogene Therapeutics

Market Cap: US$684.1m

A clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases.

4D Molecular Therapeutics

Market Cap: US$673.4m

A late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.

Assembly Biosciences

Market Cap: US$670.9m

A biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide.

Tectonic Therapeutic

Market Cap: US$664.3m

A biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs).

Zevra Therapeutics

Market Cap: US$663.9m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

OrthoPediatrics

Market Cap: US$653.0m

A medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally.

Knight Therapeutics

Market Cap: CA$904.7m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

SOPHiA GENETICS

Market Cap: US$648.7m

Operates as a cloud-native software technology company in the healthcare space.

AngioDynamics

Market Cap: US$647.3m

A medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally.

Starling Oncology

Market Cap: US$638.0m

An oncology company, provides various oncology services in the United States.

Tilray Brands

Market Cap: US$637.4m

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.

Cytek Biosciences

Market Cap: US$635.6m

A cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications.

CorMedix

Market Cap: US$634.5m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.